Atossa Genetics Inc. Securities Investigation
The White Law Group is investigating potential claims involving brokerage firms for the unsuitable sale and recommendation of investments in Atossa Genetics Inc. The company’s common shares of common stock are listed on the Nasdaq Capital Market under the symbol “ATOS.”
In September 2016, Atossa Genetics Inc. offered 1,150,000 shares of common stock for sale to investors. The offering amount was $2,875,000. As of February 28, 2024, the post offering return was -96.7%.
Atossa Genetics Inc. Background and Latest News
According to its website, Atossa Therapeutics (formerly Atossa Genetics) is a clinical-stage biopharmaceutical company focusing on breast cancer treatment and other breast conditions.
Risks Associated with Small Stock Offerings:
- Lack of Information: Many small companies may not provide comprehensive financial disclosures or have limited operating histories.
- Market Volatility: Small stocks can be more volatile than larger, established companies, leading to significant price fluctuations.
- Liquidity Concerns: These stocks may have low trading volumes, making it difficult to buy or sell shares at desired prices.
In addition to these risks, there are the risks associated with pharmaceutical and biotech investments. The research and development process for pharma companies often involves costly and lengthy testing trials that yield specific data. If the expected data or end points are not met, that could be bad news for investors.
Broker Responsibilities and Investor Protections
Broker dealers are required to conduct thorough due diligence on any investment they recommend and ensure that all recommendations are suitable for their clients. Firms that fail in this duty may be held liable for investor losses through FINRA arbitration claims.
If a broker or brokerage firm makes an unsuitable investment recommendation or fails to disclose the associated risks adequately, they may be found liable for investment losses in a FINRA arbitration claim. Fortunately, FINRA provides an arbitration forum for investors to resolve such disputes.
Recovery of Investment Losses
If you have suffered investment losses in Atossa Genetics Inc., you may have recovery options. The securities attorneys at The White Law Group offer free consultations and can be reached at 1-888-637-5510.
About The White Law Group
The White Law Group is a national securities fraud, securities arbitration, and investor protection law firm with offices in Chicago, Illinois and Seattle, Washington. The firm represents investors across the country in claims against their brokerage firms.
Last modified: August 2, 2024
